Lazard Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,668
| Closed | -$1K | – | 2511 |
|
|
2025
Q1 | $1K | Sell |
2,668
-43,795
| -94% | -$16.4K | ﹤0.01% | 2265 |
|
|
2024
Q4 | $47K | Buy |
+46,463
| New | +$47K | ﹤0.01% | 1982 |
|
|
2024
Q3 | – | Sell |
-865
| Closed | – | – | 2440 |
|
|
2024
Q2 | $0 | Sell |
865
-22,572
| -96% | – | ﹤0.01% | 2409 |
|
|
2024
Q1 | $15K | Sell |
23,437
-13,653
| -37% | -$8.74K | ﹤0.01% | 1859 |
|
|
2023
Q4 | $19K | Buy |
37,090
+2,039
| +6% | +$1.05K | ﹤0.01% | 2060 |
|
|
2023
Q3 | $20K | Sell |
35,051
-45,027
| -56% | -$25.7K | ﹤0.01% | 2098 |
|
|
2023
Q2 | $104K | Buy |
80,078
+67,489
| +536% | +$87.7K | ﹤0.01% | 1564 |
|
|
2023
Q1 | $21K | Sell |
12,589
-11,621
| -48% | -$19.4K | ﹤0.01% | 2049 |
|
|
2022
Q4 | $75K | Sell |
24,210
-2,754
| -10% | -$8.53K | ﹤0.01% | 1638 |
|
|
2022
Q3 | $131K | Buy |
26,964
+45
| +0.2% | +$219 | ﹤0.01% | 1369 |
|
|
2022
Q2 | $111K | Buy |
26,919
+14,751
| +121% | +$60.8K | ﹤0.01% | 1472 |
|
|
2022
Q1 | $70K | Buy |
12,168
+3,342
| +38% | +$19.2K | ﹤0.01% | 1565 |
|
|
2021
Q4 | $65K | Buy |
8,826
+1,560
| +21% | +$11.5K | ﹤0.01% | 1629 |
|
|
2021
Q3 | $65K | Sell |
7,266
-8,990
| -55% | -$80.4K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $193K | Buy |
16,256
+16,030
| +7,093% | +$190K | ﹤0.01% | 1220 |
|
|
2021
Q1 | $2K | Sell |
226
-5,121
| -96% | -$45.3K | ﹤0.01% | 1813 |
|
|
2020
Q4 | $83K | Buy |
+5,347
| New | +$83K | ﹤0.01% | 1229 |
|